CVS Health Prepares to Unveil Q4 Earnings Amid Mixed Market Signals CVS is set to release its fourth-quarter earnings this Wednesday. Analysts forecast an earnings per share (EPS) of 94 cents and total revenues of $97.20 billion, with the announcement scheduled before market hours.

Over the past year, CVS’s stock has fallen by 29.78%, though it has rebounded with a year-to-date increase of 22.72%.

Let’s delve into how the stock charts are shaping up and how CVS’s performance aligns with Wall Street’s expectations.

Find Out More: Analysts Weigh In on Top High-Dividend Health Care Stocks

Positive Trends for CVS Stock Ahead of Earnings

Currently, CVS stock presents a mostly optimistic trend, trading above its five, 20, and 50-day exponential moving averages (EAMAs). This suggests growing buying pressure, offering a hopeful signal for future upward movements.

Chart created using Benzinga Pro

Despite this positivity, some technical indicators tell a different story. As of now, CVS stock is priced at $54.34, which is below the eight-day simple moving average (SMA) of $55.17, suggesting a short-term bearish trend. The 20-day SMA stands at $54.54, also leaning bearish but only mildly.

On a brighter note, the stock is above its 50-day SMA of $51.58, which is generally encouraging. The Moving Average Convergence Divergence (MACD) reads at 1.18, supporting a bullish view. Additionally, CVS Health’s Relative Strength Index (RSI) is currently at 55.03, indicating that the stock is neither overbought nor oversold, and could move higher. However, the price remains under its 200-day SMA of $56.98, which poses some resistance.

In summary, while CVS Health shows strong bullish signals in the near and medium term, resistance from longer-term averages may constrain growth unless the stock breaks through these critical levels. Investors should keep an eye on these mixed signals and watch for any breakout above significant resistance.

Analysts Predict 17% Upside for CVS

Current Ratings & Future Projections: The consensus rating on CVS stock is currently a Buy, with an average price target of $78.63. Recent ratings from analysts at Evercore ISI Group, Truist Securities, and Deutsche Bank average to a price target of $63.67, indicating a potential 17% upside for investors.

CVS Stock Price Update: As of Tuesday, CVS stock was trading at $54.25, down by 0.11% at the time of publication.

Learn More Next:

Photo: Shutterstock